Hc1 CEO, Bradley Bostic Recognized As A 2026 Notable Leader In Health Care For Driving AI-Powered Health System Transformation

INDIANAPOLIS--(BUSINESS WIRE)--hc1^®, the leader in agentic lab data intelligence for healthcare, today announced that its Founder, Chairman, and CEO, Bradley Bostic, has been named to the prestigious Crain's Chicago Business Notable Leaders in Health Care 2026 list. This recognition highlights Bostic's commitment to advancing healthcare delivery by utilizing AI-driven insights to maximize cost savings, reduce waste, and drive operational efficiency across comprehensive health systems.

Under Bostic's visionary leadership, the hc1 IQ™ agentic intelligence platform is positioned at the forefront of healthcare innovation. By unifying clinical intelligence, operational analytics, supply chain optimization, and market growth into a single AI-powered ecosystem, hc1 IQ™ eliminates data silos and delivers actionable insights that drive measurable outcomes. By leveraging this advanced AI technology, hc1 empowers health systems to reclaim control of their complex operations and transform their vast data networks into a unified strategic asset. This forward-thinking approach provides critical operational support, enabling healthcare decision-makers to optimize their overarching expenditures, achieve substantial cost savings, and enhance comprehensive clinical readiness across the entire continuum of care.

"Data and diagnostics in the era of AI can unlock value across an entire health system," said Bostic. "By unifying clinical intelligence, operational analytics, and supply chain optimization into a single AI-powered ecosystem, we are eliminating silos and providing the actionable insights necessary to make patients healthier while also improving financial performance for health systems.”

The Crain's Chicago Business Notable Leaders in Health Care 2026 list celebrates executives, innovators, and visionaries who are actively shaping care delivery and policy. Honorees are selected based on their demonstrable impact on strengthening data systems, improving value-based contracting, and advancing institutional adaptations. Bostic's inclusion in this select group underscores the transformative potential of hc1's technology to ensure a bright future for the US healthcare system and the patients it serves.

About hc1^®

hc1 IQ™ is the leading AI-powered platform designed to unlock the full potential of actionable lab data, transforming it into strategic insights that drive better patient care and measurable financial outcomes. By combining advanced data management, analytics, and workflow automation, hc1 IQ™ uncovers hidden risk signals and actionable insights, enabling healthcare organizations to achieve operational excellence, clinical innovation, and revenue growth across the care continuum. Trusted by over 1,000 healthcare organizations and processing more than 25 billion lab results, hc1 IQ™ delivers the expertise and technology needed to turn lab data into a strategic asset. Learn how hc1 IQ™ is revolutionizing healthcare at www.hc1.ai.

Contacts

Media Contact: Marcus Gordon, Vice President, Marketing
mgordon@hc1.com